Cryo-Cell International, Inc.
CCEL · NASDAQ
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | 0.87 | -0.50 | 0.03 |
| FCF Yield | 6.60% | 1.56% | 1.40% | 2.86% |
| EV / EBITDA | 21.90 | 31.02 | 56.61 | 341.71 |
| Quality | ||||
| ROIC | 3.93% | 2.13% | 1.16% | -0.26% |
| Gross Margin | 76.98% | 76.58% | 75.10% | 79.60% |
| Cash Conversion Ratio | 3.38 | 1.99 | 3.37 | -1.16 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.55% | 1.01% | 1.28% | 1.78% |
| Free Cash Flow Growth | 287.51% | -27.74% | -55.74% | -4.86% |
| Safety | ||||
| Net Debt / EBITDA | 2.07 | 5.55 | 9.96 | 51.02 |
| Interest Coverage | 3.53 | 2.71 | 2.13 | -0.16 |
| Efficiency | ||||
| Inventory Turnover | 2.75 | 2.74 | 2.72 | 2.49 |
| Cash Conversion Cycle | -97.76 | 2.83 | -9.88 | 14.64 |